Hereditary hemorrhagic telangiectasia Osler Weber Rendu syndrome and management with bevacizumab

Combariza, Juan Felipe; Olaya, Viviana Patricia

Services on Demand

Journal

SciELO Analytics
Google Scholar H5M5 ()

Article

Spanish (pdf)
Article in xml format
Article references
How to cite this article
SciELO Analytics

Automatic translation
Send this article by e-mail

Indicators

Cited by SciELO
Access statistics

Acta Medica Colombiana

Print version ISSN 0120-2448

Abstract

COMBARIZA, Juan Felipe and OLAYA, Viviana Patricia. Hereditary hemorrhagic telangiectasia Osler Weber Rendu syndrome and management with bevacizumab. Acta Med Colomb [online]. 2015, vol.40, n.1, pp.66-68. ISSN 0120-2448.

The case of a patient diagnosed with hereditary hemorrhagic telangiectasia with multiple systemic manifestations due to profuse bleeding, severe anemia and pulmonary arteriovenous malformations, liver and heart failure high debit adequate response to the use of bevacizumab, is presented. (Acta Med Colomb 2015; 40: 66-68).

Keywords : hereditary hemorrhagic telangiectasia; Osler Weber Rendu; bevacizumab; arterio-venous malformations.

· abstract in Spanish · text in Spanish · Spanish (

pdf )